Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma

por van Bruggen, Jaco A. C., Martens, Anne W. J., Tonino, Sanne H., Kater, Arnon P.
Publicado 2020

Correction: van Bruggen et al. Overcoming the Hurdles of Autologous T-Cell-Based Therapies in B-Cell Non-Hodgkin Lymphoma. Cancers 2020, 12, 3837

por van Bruggen, Jaco A. C., Martens, Anne W. J., Tonino, Sanne H., Kater, Arnon P.
Publicado 2021

Innate Lymphoid Cells in Tumor Immunity

por van Beek, Jasper J. P., Martens, Anne W. J., Bakdash, Ghaith, de Vries, I. Jolanda M.
Publicado 2016

Ligand-dependent downregulation of MR1 cell surface expression

por Salio, Mariolina, Awad, Wael, Veerapen, Natacha, Gonzalez-Lopez, Claudia, Kulicke, Corinna, Waithe, Dominic, Martens, Anne W. J., Lewinsohn, David M., Hobrath, Judith V., Cox, Liam R., Rossjohn, Jamie, Besra, Gurdyal S., Cerundolo, Vincenzo
Publicado 2020

CD3xCD19 DART molecule treatment induces non-apoptotic killing and is efficient against high-risk chemotherapy and venetoclax-resistant chronic lymphocytic leukemia cells

por Martens, Anne W J, Janssen, Susanne R, Derks, Ingrid A M, Adams III, Homer C, Izhak, Liat, van Kampen, Roel, Tonino, Sanne H, Eldering, Eric, van der Windt, Gerritje J W, Kater, Arnon P
Publicado 2020

Chronic lymphocytic leukemia presence impairs antigen-specific CD8(+) T-cell responses through epigenetic reprogramming towards short-lived effectors

por Martens, Anne W. J., Kavazović, Inga, Krapić, Mia, Pack, Su Min, Arens, Ramon, Jongejan, Aldo, Moerland, Perry D., Eldering, Eric, van der Windt, Gerritje J. W., Wensveen, Felix M., Peters, Fleur S., Kater, Arnon P.
Publicado 2023

Human CXCR5(+)PD‐1(+) CD8 T cells in healthy individuals and patients with hematologic malignancies

por Hofland, Tom, Martens, Anne W.J., van Bruggen, Jaco A.C., de Boer, Renate, Schetters, Sjoerd, Remmerswaal, Ester B.M., Bemelman, Frederike J., Levin, Mark‐David, Bins, Adriaan D., Eldering, Eric, Kater, Arnon P., Tonino, Sanne H.
Publicado 2020

Redirecting T-cell Activity with Anti-BCMA/Anti-CD3 Bispecific Antibodies in Chronic Lymphocytic Leukemia and Other B-cell Lymphomas

por Martens, Anne W.J., Rietveld, Joanne M., de Boer, Renate, Peters, Fleur S., Ngo, An, van Mil, Lotte W.H.G., de Heer, Koen, Spaargaren, Marcel, Verkleij, Christie P.M., van de Donk, Niels W.C.J., Adams, Homer C., Eldering, Eric, van Noesel, Carel J.M., Verona, Raluca, Kater, Arnon P.
Publicado 2022